Invesco’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$372M Buy
4,316,654
+430,249
+11% +$38.6M 0.04% 436
2025
Q4
$339M Buy
3,886,405
+3,595,339
+1,235% +$273M 0.03% 457
2025
Q3
$16.7M Sell
291,066
-630,482
-68% -$36.3M ﹤0.01% 1542
2025
Q2
$54.4M Sell
921,548
-1,099,608
-54% -$71M 0.01% 1029
2025
Q1
$148M Buy
2,021,156
+1,553,154
+332% +$128M 0.03% 697
2024
Q4
$38.7M Buy
468,002
+191,720
+69% +$15.1M 0.01% 1158
2024
Q3
$19.8M Buy
276,282
+59,138
+27% +$4.17M ﹤0.01% 1468
2024
Q2
$14.9M Sell
217,144
-28,074
-11% -$1.68M ﹤0.01% 1577
2024
Q1
$13.2M Sell
245,218
-33,353
-12% -$1.79M ﹤0.01% 1669
2023
Q4
$14.8M Sell
278,571
-34,766
-11% -$1.69M ﹤0.01% 1581
2023
Q3
$15.6M Buy
313,337
+122,039
+64% +$6.82M ﹤0.01% 1479
2023
Q2
$11.4M Sell
191,298
-14,612
-7% -$833K ﹤0.01% 1722
2023
Q1
$11.7M Sell
205,910
-1,673,520
-89% -$107M ﹤0.01% 1673
2022
Q4
$140M Buy
1,879,430
+123,137
+7% +$8.38M 0.04% 585
2022
Q3
$105M Sell
1,756,293
-133,441
-7% -$8.04M 0.03% 646
2022
Q2
$106M Buy
1,889,734
+613,247
+48% +$40.3M 0.03% 666
2022
Q1
$94.2M Sell
1,276,487
-238,137
-16% -$16.6M 0.02% 779
2021
Q4
$109M Buy
1,514,624
+275,596
+22% +$20M 0.03% 771
2021
Q3
$94.9M Buy
1,239,028
+209,077
+20% +$16.8M 0.02% 830
2021
Q2
$79.9M Sell
1,029,951
-132,518
-11% -$9.42M 0.02% 907
2021
Q1
$71.7M Buy
1,162,469
+579,306
+99% +$36.7M 0.02% 924
2020
Q4
$38M Sell
583,163
-293,156
-33% -$16.9M 0.01% 1118
2020
Q3
$43.4M Sell
876,319
-195,617
-18% -$10.1M 0.01% 993
2020
Q2
$51.1M Buy
1,071,936
+585,019
+120% +$28.2M 0.02% 893
2020
Q1
$20.7M Buy
486,917
+57,950
+14% +$2.86M 0.01% 1185
2019
Q4
$25.3M Sell
428,967
-41,668
-9% -$2.26M 0.01% 1289
2019
Q3
$24.1M Sell
470,635
-156,437
-25% -$7.45M 0.01% 1308
2019
Q2
$26.5M Buy
627,072
+264,790
+73% +$11.5M 0.01% 1291
2019
Q1
$17.9M Buy
362,282
+94,247
+35% +$4.26M 0.01% 1285
2018
Q4
$11.6M Buy
268,035
+29,424
+12% +$1.47M ﹤0.01% 1462
2018
Q3
$13.5M Buy
238,611
+3,792
+2% +$200K ﹤0.01% 1531
2018
Q2
$11.8M Buy
234,819
+203,350
+646% +$10.6M ﹤0.01% 1563
2018
Q1
$1.57M Sell
31,469
-14,546
-32% -$684K ﹤0.01% 2758
2017
Q4
$1.89M Buy
46,015
+1,373
+3% +$48.1K ﹤0.01% 2628
2017
Q3
$1.33M Buy
44,642
+1,363
+3% +$41.6K ﹤0.01% 2846
2017
Q2
$1.44M Buy
43,279
+633
+1% +$19.9K ﹤0.01% 2793
2017
Q1
$1.26M Buy
42,646
+12,206
+40% +$333K ﹤0.01% 2902
2016
Q4
$755K Sell
30,440
-390
-1% -$8.86K ﹤0.01% 3142
2016
Q3
$696K Sell
30,830
-1,589,715
-98% -$37.4M ﹤0.01% 3125
2016
Q2
$38.6M Buy
1,620,545
+28,414
+2% +$681K 0.01% 869
2016
Q1
$37.8M Sell
1,592,131
-20,143
-1% -$492K 0.02% 863
2015
Q4
$44.9M Buy
1,612,274
+5,051
+0.3% +$127K 0.02% 807
2015
Q3
$33.2M Sell
1,607,223
-72,033
-4% -$1.82M 0.01% 925
2015
Q2
$43.1M Buy
1,679,256
+26,229
+2% +$664K 0.02% 869
2015
Q1
$41.7M Sell
1,653,027
-8,337
-0.5% -$203K 0.02% 888
2014
Q4
$39.5M Buy
1,661,364
+357,568
+27% +$7.92M 0.02% 912
2014
Q3
$25.6M Sell
1,303,796
-28,601
-2% -$588K 0.01% 1089
2014
Q2
$31.9M Buy
1,332,397
+197,348
+17% +$4.76M 0.01% 1016
2014
Q1
$30.2M Buy
1,135,049
+1,068,698
+1,611% +$25.4M 0.01% 1028
2013
Q4
$1.34M Buy
66,351
+63,706
+2,409% +$1.18M ﹤0.01% 2923
2013
Q3
$46K Sell
2,645
-58,483
-96% -$1.01M ﹤0.01% 4089
2013
Q2
$1.03M Buy
+61,128
New +$943K ﹤0.01% 2846

Other funds holding GMED

Invesco's GMED Position: Q1 2026 in Review

Invesco increased its Globus Medical (GMED) stake by 11% in Q1 2026, buying an estimated $38.6M and bringing the position to 4,316,654 shares worth $372M. The position accounts for 0.04% of the portfolio, ranked #436.

Invesco first reported a position in GMED in Q2 2013 and has held it in 52 quarters since. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Invesco held 4,316,654 shares of Globus Medical worth $372M as of Q1 2026.
  • Invesco bought 430,249 Globus Medical shares in Q1 2026, an estimated $38.6M.
  • Globus Medical made up 0.04% of Invesco's portfolio in Q1 2026, its #436 holding.
  • Invesco first reported a position in Globus Medical in Q2 2013 and has held it in 52 quarters since.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.